IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cardiomyopathy
- Premature Ventricular Contraction (PVC)
- Ventricular Arrhythmia
- Ventricular Tachycardia
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Sudden cardiac death (SCD), predominantly due to ventricular tachyarrhythmias, is a leading cause of mortality in the United States and around the world. Catheter ablation of ventricular arrhythmias has proven efficacious in reducing the burden of arrhythmias and reducing implantable cardiac defibri...
Sudden cardiac death (SCD), predominantly due to ventricular tachyarrhythmias, is a leading cause of mortality in the United States and around the world. Catheter ablation of ventricular arrhythmias has proven efficacious in reducing the burden of arrhythmias and reducing implantable cardiac defibrillator (ICD) shocks. The aim of this study is to create a prospective international database registry that will allow for better assessment of the outcomes of catheter ablation of ventricular arrhythmias. The registry, with approximately 30 participating centers, will help to identify the overall success rates and associated benefits of the procedure and provide more comprehensive data on understudied populations and treatment.
Tracking Information
- NCT #
- NCT04520347
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Jason Bradfield, MD University of California, Los Angeles Study Chair: Kalyanam Shivkumar, MD, PhD University of California, Los Angeles Study Chair: Paolo Della Bella, MD San Raffaele Hospital, Italy Study Chair: Francis Marchlinski, MD, FACC, FAHA, FHRS University of Pennsylvania Health System Study Chair: Andrea Natale, MD, FACC, FHRS, FESC Texas Cardiac Arrhythmia Institute at St. David's Medical Center Study Chair: William G Stevenson, MD Vanderbilt Heart and Vascular Institute